References:
Avinash Kharat, Vikrant Patil, Supriya Kheur, R. B. (2019) ‘Airway delivery of conditioned media from mesenchymal stem cells (MSC-CM) for COPD’, Pulmonary Pharmacology & Therapeutics , https://do.
Leng, Z. et al. (2020) ‘Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia’,ChinaXiv , 11(2), pp. 216–228.
Ullah, I., Subbarao, R. B. and Rho, G. J. (2015) ‘Human mesenchymal stem cells - Current trends and future prospective’, Bioscience Reports , 35. doi: 10.1042/BSR20150025.
WHO (2020) ‘WHO COVID-19 Situation reports’, (March). Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, S. L. (2020) ‘Molecular immune pathogenesis and diagnosis of COVID-19’.